KEY POINTS
- Two tests are commonly used to screen for prostate cancer.
- If you are thinking about being screened, learn about the possible benefits and harms.
Overview
Cancer screening means looking for cancer before it causes symptoms. The goal of screening for prostate cancer is to find cancers that may be at high risk for spreading if not treated and to find them early before they spread.
If you are considering being screened, it’s important to learn about the possible benefits and harms of screening, diagnosis, and treatment, and talk to your doctor about your personal risk factors.
There is no standard test to screen for prostate cancer. Two commonly used tests are described below.
Prostate Specific Antigen (PSA) Test
A blood test called a prostate specific antigen (PSA) test measures the level of PSA in the blood. PSA is a substance made by the prostate, and its levels can be higher in men who have prostate cancer. However, PSA levels may also be elevated due to other conditions affecting the prostate.
As a rule, the higher the PSA level in the blood, the more likely it is that a prostate problem is present. But many factors, such as age and race, can affect PSA levels. Some prostate glands naturally make more PSA than others. PSA levels can also be influenced by:
- Certain medical procedures
- Certain medications
- An enlarged prostate
- A prostate infection
Because many factors can affect PSA levels, your doctor is the best person to interpret your PSA test results. If the PSA test is abnormal, your doctor may recommend a biopsy to determine if you have prostate cancer.
Digital Rectal Examination (DRE)
A digital rectal examination (DRE) is when a healthcare provider inserts a gloved, lubricated finger into a man’s rectum to feel the prostate for abnormalities, such as cancer. However, the US Preventive Services Task Force does not recommend DRE as a screening test due to a lack of evidence on its benefits.
Updates
Recent discussions in the medical community emphasize the importance of informed decision-making when it comes to prostate cancer screening. While the PSA test remains a valuable tool, it is crucial to understand that not all elevated PSA levels indicate cancer, and not all prostate cancers require immediate treatment. Advances in medical research continue to improve our understanding of prostate cancer and how best to screen and treat it.
In conclusion, if you are considering prostate cancer screening, consult with your doctor to understand the potential benefits and risks based on your individual health profile. Early detection can be key to effective treatment, but informed choices are essential to navigate the complexities of prostate cancer screening.
Stay well! Stay informed! Stay safe!
Dr. Kesler Dalmacy
Disclaimer:
No blog articles can replace the expertise of a licensed physician. This open letter/article in this website/DrDalmacy.com blog platform is intended solely for informational and educational purposes. This blog is not intended as medical advice. Please make certain that you consult your doctor or a qualified clinician or medical professional before making any decisions affecting your health, particularly if you have any symptoms that require treatment. Neither Dr. Kesler Dalmacy, nor DrDalmacy.com accept liability should you choose to self-prescribe or treat yourself.